Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fokas

Showing results (261-270 of 329) with videos related to

Pageof 33
Sort By:
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 26, 2022
Clinical outcome after total neoadjuvant treatment (CAO/ARO/AIO-12) versus intensified neoadjuvant and adjuvant treatment (CAO/ARO/AIO-04) a comparison between two multicenter randomized phase II/III trialsMarkus Diefenhardt, Maximillian Fleischmann, Daniel Martin, et al.
Neuro-Oncology Advances|November 29, 2023
Gliomatosis cerebri (GC) growth pattern: A single-center analysis of clinical, histological, and molecular characteristics of GC and non-GC glioblastomaIris Divé, Katharina J Weber, Tabea I Hartung, et al.
EMBO Molecular Medicine|December 10, 2016
PD-L1 blockade enhances response of pancreatic ductal adenocarcinoma to radiotherapyAbul Azad, Su Yin Lim, Zenobia D'Costa, et al.
Hepatology (Baltimore, Md.)|January 31, 2017
Neutrophils promote hepatic metastasis growth through fibroblast growth factor 2-dependent angiogenesis in miceAlex N Gordon-Weeks, Su Y Lim, Arseniy E Yuzhalin, et al.
Oncology Letters|July 12, 2017
Bevacizumab as a last-line treatment for glioblastoma following failure of radiotherapy, temozolomide and lomustineKatharina J Wenger, Marlies Wagner, Se-Jong You, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 7, 2018
Impact of age on the efficacy of oxaliplatin in the preoperative chemoradiotherapy and adjuvant chemotherapy of rectal cancer: a post hoc analysis of the CAO/ARO/AIO-04 phase III trialR-D Hofheinz, D Arnold, E Fokas, et al.
Frontiers in Oncology|September 3, 2019
Association of Polo-Like Kinase 3 and PhosphoT273 Caspase 8 Levels With Disease-Related Outcomes Among Cervical Squamous Cell Carcinoma Patients Treated With Chemoradiation and BrachytherapyMax Fleischmann, Daniel Martin, Samuel Peña-Llopis, et al.
Cancer Research|January 7, 2021
A Spatial and Functional Interaction of a Heterotetramer Survivin-DNA-PKcs Complex in DNA Damage ResponseÖmer Güllülü, Stephanie Hehlgans, Benjamin E Mayer, et al.
Radiation Oncology (London, England)|January 3, 2025
Optimising (re-)irradiation for locally recurrent head and neck cancer: impact of dose-escalation, salvage surgery, PEG tube and biomarkers on oncological outcomes-a single centre analysisJulia Katharina Schleifenbaum, Janis Morgenthaler, Shachi Jenny Sharma, et al.
Journal of the National Cancer Institute|December 6, 2017
Tumor Regression Grading After Preoperative Chemoradiotherapy as a Prognostic Factor and Individual-Level Surrogate for Disease-Free Survival in Rectal CancerEmmanouil Fokas, Philipp Ströbel, Rainer Fietkau, et al.
Pageof 33

Showing results (261-270 of 329) with videos related to

Sort By:
Pageof 33
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 26, 2022
Clinical outcome after total neoadjuvant treatment (CAO/ARO/AIO-12) versus intensified neoadjuvant and adjuvant treatment (CAO/ARO/AIO-04) a comparison between two multicenter randomized phase II/III trialsMarkus Diefenhardt, Maximillian Fleischmann, Daniel Martin, et al.
Neuro-Oncology Advances|November 29, 2023
Gliomatosis cerebri (GC) growth pattern: A single-center analysis of clinical, histological, and molecular characteristics of GC and non-GC glioblastomaIris Divé, Katharina J Weber, Tabea I Hartung, et al.
EMBO Molecular Medicine|December 10, 2016
PD-L1 blockade enhances response of pancreatic ductal adenocarcinoma to radiotherapyAbul Azad, Su Yin Lim, Zenobia D'Costa, et al.
Hepatology (Baltimore, Md.)|January 31, 2017
Neutrophils promote hepatic metastasis growth through fibroblast growth factor 2-dependent angiogenesis in miceAlex N Gordon-Weeks, Su Y Lim, Arseniy E Yuzhalin, et al.
Oncology Letters|July 12, 2017
Bevacizumab as a last-line treatment for glioblastoma following failure of radiotherapy, temozolomide and lomustineKatharina J Wenger, Marlies Wagner, Se-Jong You, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 7, 2018
Impact of age on the efficacy of oxaliplatin in the preoperative chemoradiotherapy and adjuvant chemotherapy of rectal cancer: a post hoc analysis of the CAO/ARO/AIO-04 phase III trialR-D Hofheinz, D Arnold, E Fokas, et al.
Frontiers in Oncology|September 3, 2019
Association of Polo-Like Kinase 3 and PhosphoT273 Caspase 8 Levels With Disease-Related Outcomes Among Cervical Squamous Cell Carcinoma Patients Treated With Chemoradiation and BrachytherapyMax Fleischmann, Daniel Martin, Samuel Peña-Llopis, et al.
Cancer Research|January 7, 2021
A Spatial and Functional Interaction of a Heterotetramer Survivin-DNA-PKcs Complex in DNA Damage ResponseÖmer Güllülü, Stephanie Hehlgans, Benjamin E Mayer, et al.
Radiation Oncology (London, England)|January 3, 2025
Optimising (re-)irradiation for locally recurrent head and neck cancer: impact of dose-escalation, salvage surgery, PEG tube and biomarkers on oncological outcomes-a single centre analysisJulia Katharina Schleifenbaum, Janis Morgenthaler, Shachi Jenny Sharma, et al.
Journal of the National Cancer Institute|December 6, 2017
Tumor Regression Grading After Preoperative Chemoradiotherapy as a Prognostic Factor and Individual-Level Surrogate for Disease-Free Survival in Rectal CancerEmmanouil Fokas, Philipp Ströbel, Rainer Fietkau, et al.
Pageof 33